1-deazaadenosine,
1-Deazaadenosine,
1-deaza-adenosine,
14432-09-8,
CHEMBL115824,
3H-Imidazo(4,5-b)pyridin-7-amine, 3-beta-D-ribofuranosyl-,
1DA,
3H-Imidazo[4,5-b]pyridin-7-amine, 3-beta-D-ribofuranosyl-,
1add,
1-Deaza-A,
AC1L4ME8,
AC1Q4XY1,
adenosine-N,1,3-15N3,
SCHEMBL18490353,
3-(|A-d-ribofuranosyl)-3h-imidazo[4,5-b]pyridin-7-amine,
ZINC3814313,
BDBM50060165,
PDSP1_001078,
PDSP2_001062,
AKOS024458188,
DB04218,
NCGC00163308-01,
3-?-D-Ribofuranosyl-3H-imidazo[4,5-b]pyridin-7-amine,
3-beta-D-ribofuranosyl-3H-imidazo[4,5-b]pyridin-7-amine,
(2R,3R,4S,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-(hydroxymethyl)oxolane-3,4-diol,
3H-Imidazo[4,5-B]Pyridine, 7-Amino-3-ss-D-Ribofuranosyl- (8Ci); 1-Deazaadenosine,
(2R,3R,4S,5R)-2-(7-amino-3H-imidazo[4,5-b]pyridin-3-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol,
(2R,3R,4S,5R)-2-(7-Amino-imidazo[4,5-b]pyridin-3-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol,
(2R,3R,4S,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol,
244769-66-2,
Resiquimod,
D03PLV,
AR-1E8103,
AR-1E8104,
CID159738,
C11-H14-N4-O4,
C048086,
3H-Imidazo[4,5-b]pyridin-7-amine, 3-.beta.-D-ribofuranosyl-,
3H-Imidazo[4,5-b]pyridine, 7-amino-3-.beta.-D-ribofuranosyl-,
144875-48-9,
17064-95-8,
17066-70-5,